Hepion Pharmaceuticals, Inc. (HEPA)
OTCMKTS · Delayed Price · Currency is USD
0.0575
+0.0055 (10.58%)
At close: Jun 15, 2026
Hepion Pharmaceuticals Market Cap
Hepion Pharmaceuticals has a market cap or net worth of $1.67 million as of June 16, 2026. Its market cap has increased by 57.91% in one year.
Market Cap
1.67M
Enterprise Value
766.92K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since February 10, 2014, Hepion Pharmaceuticals's market cap has decreased from 13.86M to 1.67M, a decrease of -87.92%. That is a compound annual growth rate of -15.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 1.67M | 140.15% |
| Dec 31, 2025 | 697.22K | -78.69% |
| Dec 31, 2024 | 3.27M | -76.72% |
| Dec 29, 2023 | 14.05M | -38.61% |
| Dec 30, 2022 | 22.89M | -73.66% |
| Dec 31, 2021 | 86.90M | 23.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VitaSpring Biomedical | 2.30M |
| ProtoKinetix | 2.14M |
| Iterum Therapeutics | 2.11M |
| Bio-Path Holdings | 1.91M |
| AXIM Biotechnologies | 1.69M |
| ZyVersa Therapeutics | 1.58M |
| inTerra Resources | 1.47M |
| Clearside Biomedical | 1.42M |